KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) Equity Income: 2009-2024

Historic Equity Income for Quest Diagnostics (DGX) over the last 16 years, with Dec 2024 value amounting to $19.0 million.

  • Quest Diagnostics' Equity Income rose 33.33% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.0 million, marking a year-over-year increase of 42.86%. This contributed to the annual value of $19.0 million for FY2024, which is 26.92% down from last year.
  • Latest data reveals that Quest Diagnostics reported Equity Income of $19.0 million as of FY2024, which was down 26.92% from $26.0 million recorded in FY2023.
  • In the past 5 years, Quest Diagnostics' Equity Income registered a high of $78.0 million during FY2021, and its lowest value of $19.0 million during FY2024.
  • In the last 3 years, Quest Diagnostics' Equity Income had a median value of $26.0 million in 2023 and averaged $29.7 million.
  • Its Equity Income has fluctuated over the past 5 years, first soared by 31.58% in 2020, then slumped by 43.59% in 2022.
  • Yearly analysis of 5 years shows Quest Diagnostics' Equity Income stood at $75.0 million in 2020, then grew by 4.00% to $78.0 million in 2021, then crashed by 43.59% to $44.0 million in 2022, then tumbled by 40.91% to $26.0 million in 2023, then dropped by 26.92% to $19.0 million in 2024.